Neoantigen Peptide Manufacturing Market Future Scope and Latest Trends Analysis Report - Benzinga

GNNSF Stock  USD 1.44  0.03  2.13%   
Roughly 55% of Genscript Biotech's stockholders are presently thinking to get in. The analysis of overall sentiment of trading Genscript Biotech pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Genscript Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use Genscript Biotech stock news signals to limit their universe of possible portfolio assets.
Genscript Biotech pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Genscript daily returns and investor perception about the current price of Genscript Biotech as well as its diversification or hedging effects on your existing portfolios.
  
Neoantigen Peptide Manufacturing Market Future Scope and Latest Trends Analysis Report Benzinga

Read at news.google.com
Google News at Macroaxis
  

Genscript Biotech Fundamental Analysis

We analyze Genscript Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genscript Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genscript Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Per Share

Cash Per Share Comparative Analysis

Genscript Biotech is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Genscript Biotech Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genscript Biotech pink sheet to make a market-neutral strategy. Peer analysis of Genscript Biotech could also be used in its relative valuation, which is a method of valuing Genscript Biotech by comparing valuation metrics with similar companies.

Peers

Genscript Biotech Related Equities

ONTTFOxford Nanopore   16.24   
0%
100.0%
LCTXLineage Cell   1.92   
0%
11.0%
MRUSMerus BV   1.48   
0%
9.0%
CRNXCrinetics Pharmaceuticals   1.41   
0%
8.0%
IVBXFInnovent Biologics   0.98   
0%
6.0%
TLPPFTelix Pharmaceuticals   0.71   
4.0%
0%
KRONKronos Bio   1.04   
6.0%
0%
NXTCNextCure   1.33   
8.0%
0%
ZNTLZentalis Pharmaceuticals   1.65   
10.0%
0%
INBXInhibrx   3.46   
21.0%
0%
KROSKeros Therapeutics   4.04   
24.0%
0%
ICCCImmuCell   4.70   
28.0%
0%
NUVLNuvalent   5.19   
31.0%
0%
OVIDOvid Therapeutics   5.77   
35.0%
0%
CNTBConnect Biopharma   5.88   
36.0%
0%
NUVBNuvation Bio   6.93   
42.0%
0%
LYELLyell Immunopharma   8.11   
49.0%
0%
CVKDCadrenal Therapeutics,   8.49   
52.0%
0%

Complementary Tools for Genscript Pink Sheet analysis

When running Genscript Biotech's price analysis, check to measure Genscript Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genscript Biotech is operating at the current time. Most of Genscript Biotech's value examination focuses on studying past and present price action to predict the probability of Genscript Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genscript Biotech's price. Additionally, you may evaluate how the addition of Genscript Biotech to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Money Managers
Screen money managers from public funds and ETFs managed around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories